Minerva Neurosciences | NERV - Pe Prix À Revenus





Pe Changement Date
Acadia Pharmaceuticals 10.08 1.53 2026-03
Adma Biologics 15.02 14.71 2026-03
ALKERMES 39.33 19.8 2026-03
AstraZeneca 29.59 2.3 2026-03
BioCryst Pharmaceuticals 6.06 1.07K 2025-12
Bristol-Myers Squibb 9.08 0.2 2026-03
Cipla 35.82 12.26 2026-06
Clal Biotechnology 11.67 2.62 2022-12
Compugen 5.45 1.39 2026-03
CSL 16.16 9.59 2025-12
Eli Lilly 40.27 0.06 2026-03
GlaxoSmithKline 14.87 3.72 2026-03
Grifols 11.2 1.08 2025-12
Halozyme Therapeutics 11.35 11.8 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 29.43 4.9 2026-06
Merck 16.52 2.6 2026-03
Neurocrine Biosciences 28.09 807.38 2026-03
Novartis 20.17 2.32 2026-03
Novavax 2.01 1.07 2025-12
Pfizer 9.32 5.16 2026-03
Roche Holding 16.48 0.39 2026-06
Sanofi 11.84 0.14 2026-03
Takeda 46.52 188.53 2026-03
Vanda Pharmaceuticals 16.79 7.07 2023-06